Another Vaccine Rises, Time To Increase Asset Rotation?
Joe Quinlan, Chief Market Strategist, US Trust - BofA Private Wealth Management
With Moderna’s vaccine reporting an efficacy rate of 94.5% and the Dow hitting an all-time high of 30,000, is it time to change your investment plan?
The Morning Run also gets into US Treasuries, how RCEP will impact the US, and whether increased regulatory scrutiny in China is a concern for investors.
Produced by: Mike Gong
Presented by: Lyn Mak, Noelle Lim, Roshan Kanesan
Download the BFM mobile app. Stay at home and stay up-to-date.